Clinical Trial: Efficacy and Safety of Spironolactone in Pediatric Hemodialysis Patients With Anemia.

U.S., July 21 -- ClinicalTrials.gov registry received information related to the study (NCT07715318) titled 'Efficacy and Safety of Spironolactone in Pediatric Hemodialysis Patients With Anemia.' on July 15.

Brief Summary: The goal of this clinical trial is to learn if Spironolactone drug works to treat anemia in hemodialysis pediatric patients. It will also learn about the safety of Spironolactone drug. The main questions it aims to answer are:

In pediatric patients with anemia undergoing maintenance hemodialysis, does treatment with spironolactone, compared with standard care alone, reduce erythropoietin dose requirements while maintaining an acceptable safety profile? Researchers will compare Spironolactone drug to a standard therapy (...